The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 156 participants.
Also called NCT02870764
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 156 participants
- Registry
-
NCT02870764
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02870764. Randomized; triple masking; primary purpose treatment. Start 2016-09 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris
- Acronym
- DOLPHIN
- Condition
- Angina, Stable
- Condition
- Inflammation
- Intervention (Drug)
- Dan-shen extract
- Intervention (Drug)
- Placebo
- Intervention (Other)
- Standard medical care
- Lead sponsor
- Taizhou Fourth People's Hospital
- Collaborator
- Shanghai 10th People's Hospital
Record details
- Record id
cardio:ct-nct02870764- Content hash
ff796f479e8719e42ae8f42ac9a2a86d531f31d13f90a06d459546067eaf5e05